Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Pharmacokinetics of darunavir/ritonavir in Asian HIV-1-infected children aged ≥7 years.

Chokephaibulkit K, Prasitsuebsai W, Wittawatmongkol O, Gorowara M, Phongsamart W, Sophonphan J, Kerr SJ, Vanprapar N, Puthanakit T, Pasomsap C, Suwanlerk T, Sekar V, Burger D, Ananworanich J; HIV-NAT 113 Pharmacokinetic Study Group.

Antivir Ther. 2012;17(7):1263-9. doi: 10.3851/IMP2347. Epub 2012 Sep 6.

PMID:
22954687
2.

Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum.

Cressey TR, Stek A, Capparelli E, Bowonwatanuwong C, Prommas S, Sirivatanapa P, Yuthavisuthi P, Neungton C, Huo Y, Smith E, Best BM, Mirochnick M; IMPAACT P1026s Team.

J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):245-52. doi: 10.1097/QAI.0b013e31823ff052.

3.

HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy.

Puthanakit T, Jourdain G, Hongsiriwon S, Suntarattiwong P, Chokephaibulkit K, Sirisanthana V, Kosalaraksa P, Petdachai W, Hansudewechakul R, Siangphoe U, Suwanlerk T, Ananworanich J; HIV-NAT 086Study Team.

HIV Med. 2010 Oct 1;11(9):565-72. doi: 10.1111/j.1468-1293.2010.00828.x. Epub 2010 Mar 25.

4.

Psychosocial burden of women with abnormal Pap smears.

Phonrat B, Ruengkris T, Naksrisook S, Intalapaporn K, Jirakorbchaipong P, Pitisuttithum P.

Southeast Asian J Trop Med Public Health. 2009 May;40(3):593-601.

PMID:
19842448

Supplemental Content

Loading ...
Support Center